Optimizing Blinatumomab Use in Acute Lymphoblastic Leukemia
1 Visningar
administrator
06/15/23
In this segment, Stefan Faderl, MD, examines potential treatment settings that may optimize blinatumomab therapy in acute lymphoblastic leukemia.
Visa mer
Facebook-kommentarer
Inga kommentarer hittades